Clean Science Q2 FY27 consolidated PAT Rs 56.00 cr; revenue Rs 299.00 cr
Results$CLEAN

Clean Science Q2 FY27 consolidated PAT Rs 56.00 cr; revenue Rs 299.00 cr

Clean Science and Technology’s consolidated Total Revenue rose to Rs 299.00 cr in Q2 FY2027 from Rs 245.00 cr, while PAT was Rs 56.00 cr versus Rs 55.00 cr a year earlier.

Clean Science and Technology Ltd
Clean Science and Technology LtdReviewed and published by · How we report
2 min read
clean scienceq2 fy27earningsspecialty chemicals
ShareWhatsAppXLinkedIn

Key takeaways

  • Total Revenue Rs 299.00 cr in Q2 FY2027 vs Rs 245.00 cr in Q2 FY2026 on a consolidated basis.
  • Consolidated sale of products rose to Rs 295.00 cr in Q2 FY2027 from Rs 240.00 cr a year earlier.
  • Consolidated EBITDA was Rs 92.00 cr in Q2 FY2027 vs Rs 87.00 cr in Q2 FY2026.
  • Consolidated PAT stood at Rs 56.00 cr in Q2 FY2027 compared with Rs 55.00 cr in Q2 FY2026.
  • Raw material expenses increased to Rs 128.00 cr from Rs 96.00 cr on a consolidated basis.

Q2 FY27 · consolidated

MetricSep 2026Sep 2025Change
RevenueRs 299.00 crRs 245.00 cr+22.0%
PATRs 56.00 crRs 55.00 cr+1.8%

As reported in the filing. Figures are transcribed, not computed.

What the numbers show

  • Net margin was 18.73% of revenue, down 371 bps from 22.45%.

  • Basis: Consolidated statement of financial results, Q2 FY2027 vs Q2 FY2026 (P&L table in the investor presentation)

  • Total Revenue: Rs 299.00 cr (Q2 FY2027) vs Rs 245.00 cr (Q2 FY2026)

  • Sale of products: Rs 295.00 cr vs Rs 240.00 cr

  • Raw material expenses: Rs 128.00 cr vs Rs 96.00 cr

  • Other operating expenses: Rs 80.00 cr vs Rs 61.00 cr

  • EBITDA: Rs 92.00 cr vs Rs 87.00 cr

  • Depreciation expenses: Rs 21.00 cr vs Rs 19.00 cr

  • Finance costs: Rs 2.00 cr vs Rs 0.00 cr

  • Other Income: Rs 6.00 cr vs Rs 7.00 cr

  • Profit before tax (PBT): Rs 74.00 cr vs Rs 75.00 cr

  • Profit after tax (PAT): Rs 56.00 cr vs Rs 55.00 cr

According to the P&L table in the investor presentation, Clean Science and Technology Limited reported consolidated Total Revenue of Rs 299.00 cr for Q2 FY2027, up from Rs 245.00 cr in Q2 FY2026. Sale of products increased to Rs 295.00 cr from Rs 240.00 cr over the same period. Other operating income on the consolidated basis was Rs 4.00 cr in Q2 FY2027, compared with Rs 5.00 cr in Q2 FY2026, taking Total Revenue to Rs 299.00 cr versus Rs 245.00 cr a year earlier.

On the cost side, consolidated raw material expenses rose to Rs 128.00 cr in Q2 FY2027 from Rs 96.00 cr in Q2 FY2026, while other operating expenses increased to Rs 80.00 cr from Rs 61.00 cr. EBITDA on a consolidated basis was Rs 92.00 cr in Q2 FY2027, compared with Rs 87.00 cr in the corresponding quarter of the previous year. Depreciation expenses were Rs 21.00 cr versus Rs 19.00 cr a year ago, and finance costs were Rs 2.00 cr in Q2 FY2027 compared with Rs 0.00 cr in Q2 FY2026. Other Income stood at Rs 6.00 cr in Q2 FY2027 against Rs 7.00 cr in Q2 FY2026.

After these items, consolidated Profit before tax (PBT) for Q2 FY2027 was Rs 74.00 cr, slightly lower than Rs 75.00 cr in Q2 FY2026, as shown in the statement of financial results within the presentation. Profit after tax (PAT) on a consolidated basis came in at Rs 56.00 cr for Q2 FY2027, compared with Rs 55.00 cr in the same quarter of the previous year. The P&L table also reports PAT % of 18.9% for Q2 FY2027 versus 23.2% for Q2 FY2026 on the consolidated basis.

Track Clean Science and Technology Ltd

Cruxal reads every Clean Science and Technology Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Get every filing that moves a stock

One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.

Cruxal publishes market coverage for information only. Nothing here is investment advice.

Clean Science Q2 FY27: Revenue Rs 299 cr | Cruxal